Product NDC: | 59676-101 |
Proprietary Name: | OKT3 |
Non Proprietary Name: | muromonab-CD3 |
Active Ingredient(s): | 5 mg/5mL & nbsp; muromonab-CD3 |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 59676-101 |
Labeler Name: | Centocor Ortho Biotech Products, L.P. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA103463 |
Marketing Category: | BLA |
Start Marketing Date: | 19860719 |
Package NDC: | 59676-101-01 |
Package Description: | 5 AMPULE in 1 CARTON (59676-101-01) > 5 mL in 1 AMPULE (59676-101-00) |
NDC Code | 59676-101-01 |
Proprietary Name | OKT3 |
Package Description | 5 AMPULE in 1 CARTON (59676-101-01) > 5 mL in 1 AMPULE (59676-101-00) |
Product NDC | 59676-101 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | muromonab-CD3 |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19860719 |
Marketing Category Name | BLA |
Labeler Name | Centocor Ortho Biotech Products, L.P. |
Substance Name | MUROMONAB-CD3 |
Strength Number | 5 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | CD3 Blocker Immunosuppressant [EPC],CD3 Receptor Antagonists [MoA],CD3-directed Antibody Interactions [MoA],Decreased Immunologic Activity [PE] |